SCHEMBL8526969

SCHEMBL8526969

CC(C)(C)OC(=O)c1c(OCc2ccccc2)cc(-c2ccccc2)n2ncnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 3/20 0.39
DAPK1 P53355 1/20 0.39
SLC16A3 O15427 1/20 0.37
PTGER1 P34995 5/20 0.36
CYP2C9 P11712 1/20 0.36
PTGER4 P35408 3/20 0.36
PTGER3 P43115 3/20 0.36
PTGER2 P43116 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
BRD4 O60885 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
EGLN1 Q9GZT9 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8527782 0.88 CYP2C9 (0.37) DAPK1PTGER1CYP2C9KDM4EMAPT
SCHEMBL8520796 0.87 NR1H2 (0.39) EGLN2PTGER1NR1H2NR1H3
SCHEMBL8520679 0.86 EGLN2 (0.43) EGLN2PTGER1PTGER4PTGER3PTGER2
SCHEMBL30599272 0.84 PPARG (0.36) DAPK1PTGER1CYP2C9KDM4EMAPT
SCHEMBL31563010 0.83 TLR9 (0.33) PTGER1CYP2C9KDM4EMAPTBRD4
SCHEMBL31563009 0.83 TLR9 (0.33) PTGER1CYP2C9KDM4EMAPTBRD4
SCHEMBL8517633 0.82 PTGER1 (0.41) PTGER1CYP2C9KDM4EMAPTFFAR4
SCHEMBL12750386 0.82 ADORA3 (0.35) EGLN2PTGER1CYP2C9KDM4EMAPT
SCHEMBL8527666 0.79 SMN1; SMN2 (0.38) DAPK1PTGER1CYP2C9KDM4EMAPT
SCHEMBL30599273 0.78 ALKBH1 (0.33) PTGER1CYP2C9KDM4EMAPTFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2455381-A1 TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER Japan Tobacco, Inc. (JP) 2012-05-23 EP disclosed